SCHEMBL28643129

SCHEMBL28643129

COc1cc(NS(=O)(=O)Cl)c(C(=O)Nc2ccc(S(=O)(=O)N3CCSCC3)cc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 2/20 0.56
POLB P06746 2/20 0.54
TP53 P04637 1/20 0.54
KMT2A Q03164 5/20 0.53
MEN1 O00255 3/20 0.53
LMNA P02545 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GAA P10253 2/20 0.52
MAPT P10636 2/20 0.52
USP2 O75604 1/20 0.52
HPGD P15428 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
ABL1 P00519 1/20 0.49
RIN1 Q13671 1/20 0.49
ABCC9 O60706 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29382580 0.89 ALDH1A1 (0.59) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL422152 0.89 ALDH1A1 (0.59) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL10256187 0.88 ALDH1A1 (0.54) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL491809 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL491894 0.84 ALDH1A1 (0.55) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL12585305 0.83 ALDH1A1 (0.57) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL28461951 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL491822 0.80 ALDH1A1 (0.59) ALDH1A1KDM4EPOLBTP53KMT2A
SCHEMBL974966 0.79 SLC20A2 (0.59) ALDH1A1KDM4ETP53KMT2AMEN1
SCHEMBL490922 0.79 ALDH1A1 (0.60) ALDH1A1KDM4EPOLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113330030-A Method for determining whether a subject is suitable for treatment with an agonist of soluble guanylate cyclase (sGC) 拜耳公司 2021-08-31 CN claimed
CN-113330030-A Method for determining whether a subject is suitable for treatment with an agonist of soluble guanylate cyclase (sGC) 拜耳公司 2021-08-31 CN disclosed